Pay in 4 interest-free payments of $6.02 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
P-LLY Cautionary Statement Regarding Forward-Looking Statements This press release contains forward-looking statements (as that term is defined in the Private Securities Litigation Reform Act of 1995) about retatrutide as a potential treatment for adults with obesity or overweight and knee osteoarthritis, potential efficacy and tolerability of retatrutide, and the timeline for future readouts, presentations, and other milestones relating to retatrutide and its clinical trials and reflects Lilly's current beliefs and expectations
This makes carbs an important and beneficial part of a balanced diet
This strategy not only reduces aggregation risk but also enhances ADC circulation half-life and therapeutic performance
Negotiated prices take effect in 2026, and the list expands to 15 drugs in 2027 and 20 in 2028
